COVID-19 infection has been associated with numerous cardiac manifestations. Indeed, SARS-CoV-2 may impact on cardiovascular system through a direct myocardial infection or a secondary cardiac involvement due to hypoxia or metabolic supply-demand imbalance or prothrombotic inflammatory state. As a consequence of and besides acute myocardial damages, COVID-19 could also determine chronic cardiovascular consequences, with a significant impact on long-term prognosis, quality of life and functional capacity of COVID-19 survivors. On this basis, we aim to define the clinical and prognostic effects of myocardial involvement in COVID-19 patients.
COVID-19 infection has been associated with numerous cardiac manifestations. Indeed,
SARS-CoV-2 may impact on cardiovascular system through a direct myocardial infection or a
secondary cardiac involvement due to hypoxia or metabolic supply-demand imbalance or
prothrombotic inflammatory state. As a consequence of and besides acute myocardial damages,
COVID-19 could also determine chronic cardiovascular consequences, with a significant impact
on long-term prognosis, quality of life and functional capacity of COVID-19 survivors.
On this basis, we aim to define the clinical and prognostic effects of myocardial involvement
in COVID-19 patients, with a 1-month and 6-month follow-up composed of clinical evaluation,
electrocardiogram, trans-thoracic echocardiogram, cardiovascular magnetic resonance, chest
computerized tomography scan and cardiopulmonary exercise test.
Inclusion Criteria: patients who were hospitalized for COVID-19
Exclusion Criteria: None.
Humanitas Research Hospital
Rozzano, Milan, Italy
Centro Cardiologico Monzino
Milan, Italy
IRCCS Auxologico San Luca
Milan, Italy
IRCCS San Donato
Milan, Italy
IRCCS Istituti Clinici Scientifici Maugeri
Pavia, Italy
Giulio Stefanini, Prof.
0282247384
giulio.stefanini@hunimed.eu
Gianluigi Condorelli, Prof, Principal Investigator
Humanitas Research Hospital